UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000050282
Receipt number R000057256
Scientific Title New closure method using traction device for mucosal defects after endoscopic submucosal dissection of gastric neoplasms
Date of disclosure of the study information 2023/02/09
Last modified on 2023/02/09 12:20:03

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

New closure method using traction device for mucosal defects after endoscopic submucosal dissection of gastric neoplasms

Acronym

New closure method using traction device for mucosal defects after endoscopic submucosal dissection of gastric neoplasms

Scientific Title

New closure method using traction device for mucosal defects after endoscopic submucosal dissection of gastric neoplasms

Scientific Title:Acronym

New closure method using traction device for mucosal defects after endoscopic submucosal dissection of gastric neoplasms

Region

Japan


Condition

Condition

gastric neoplasms

Classification by specialty

Gastroenterology

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To investigate the feasibility and efficacy of a new and simple method using traction device for closing mucosal defects after gastric ESD.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

complete closure rate

Key secondary outcomes

procedure time, number of clips used, number of traction devices used, ulcer closure rate on postoperative day 3, incidence of post-ESD bleeding and delayed perforation, incidence of PECS, incidence of other adverse events, ulcer healing rate 1 month after closure


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Maneuver

Interventions/Control_1

After the submucosal layer at the lateral side of the mucosal defect was undermined, the mucosal defect is closed with clips using traction devices.

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Patients scheduled for ESD for gastric neoplasms

Key exclusion criteria

cases in which informed consent was not obtained for the study, cases in which part of the lesion extends to either the cardia or the pyloric ring, cases in which ulceration after resection of the lesion extends to 1/2 circumferential of the stomach, cases with severe organ failure, cases with abnormal blood clotting function with high bleeding risk, cases in which perforation was evident at the time of lesion resection, cases during pregnancy, patients in a situation where an urgent and obvious life crisis has occurred for some reason, and other cases that the attending physician or surgeon deems inappropriate for this study

Target sample size

30


Research contact person

Name of lead principal investigator

1st name Kazuki
Middle name
Last name Sumiyama

Organization

The Jikei University School of Medicine

Division name

Department of Endoscopy

Zip code

105-8461

Address

3-19-18, Nishishimbashi, Minato-ku

TEL

+81334331111

Email

kaz_sum@jikei.ac.jp


Public contact

Name of contact person

1st name Shingo
Middle name
Last name Ono

Organization

The Jikei University School of Medicine

Division name

Department of Endoscopy

Zip code

105-0003

Address

3-19-18, Nishishimbashi, Minato-ku

TEL

09072447358

Homepage URL


Email

onoshingo@mbe.nifty.com


Sponsor or person

Institute

The Jikei University School of Medicine

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Ethics Committee of the Jikei University School of Medicine

Address

3-19-18, Nishishimbashi, Minato-ku

Tel

+81334331111

Email

rinri@jikei.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2023 Year 02 Month 09 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2022 Year 06 Month 01 Day

Date of IRB

2022 Year 09 Month 12 Day

Anticipated trial start date

2022 Year 11 Month 01 Day

Last follow-up date

2024 Year 10 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2023 Year 02 Month 09 Day

Last modified on

2023 Year 02 Month 09 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000057256